A detailed history of Pfs Investments Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pfs Investments Inc. holds 934 shares of AMGN stock, worth $245,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
934
Previous 1,642 43.12%
Holding current value
$245,996
Previous $416,000 50.24%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $151,703 - $179,385
-708 Reduced 43.12%
934 $207,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $16,934 - $20,640
75 Added 4.79%
1,642 $416,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $6,183 - $7,857
27 Added 1.75%
1,567 $412,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $68,909 - $77,717
307 Added 24.9%
1,540 $347,000
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $90,438 - $100,642
392 Added 46.61%
1,233 $300,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $184,406 - $204,001
841 New
841 $203,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $547,230 - $637,707
-2,466 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $5.08 Million - $6.05 Million
-23,495 Reduced 90.5%
2,466 $586,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $803,206 - $893,231
3,423 Added 15.19%
25,961 $6.6 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $687,587 - $843,764
3,476 Added 18.24%
22,538 $5.32 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $867,826 - $1.15 Million
4,762 Added 33.3%
19,062 $3.86 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $667,343 - $857,766
3,527 Added 32.74%
14,300 $3.45 Million
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $554,018 - $663,828
3,182 Added 41.92%
10,773 $2.09 Million
Q2 2019

Jul 10, 2019

BUY
$166.7 - $195.41 $713,309 - $836,159
4,279 Added 129.2%
7,591 $1.41 Million
Q1 2019

Apr 05, 2019

BUY
$180.87 - $203.88 $599,041 - $675,250
3,312 New
3,312 $629,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.